All.Can Media Coverage – Korea Biomedical Review

‘Efficient cancer care meeting highest patient needs produce best treatment results’ Read the article and interview  (link here) with All.Can CEO Eduardo Pisani  that was published on 15 January 2021 in the Korea Biomedical Review  in light of the recent launch of the All.Can National…

Korea

New All.Can National Initiative in Korea

All.Can Korea is the first Asian branch of All.Can International, consisting of patient advocacy groups, healthcare professionals, public health policy experts, legal counsellor, and an industry partner, BMS Pharmaceuticals Korea Ltd. On…